Sharemaestro Newsreel

Trinity Biotech PLC (TRIB) Stock News Today

This article provides current stock information for Trinity Biotech PLC (TRIB), showing its recent trading performance with a 6.79% increase. It notes that more news is expected soon regarding earnings, analyst ratings, and key developments. The page also includes financial data like market capitalization.

Malvern company TELA Bio announces new CEO

TELA Bio, a Malvern-based medical technology company, has appointed Heather Getz as its new CEO and director, effective August 4. Getz replaces co-founder Antony Koblish and brings extensive experience in driving operational excellence and financial transformations from her previous roles at Butterfly Network and …

Treace Medical Concepts Inc (TMCI) (Q2 2026) Earnings Call Highlights: Revenue Declines 4% but ...

Treace Medical Concepts Inc (TMCI) reported a 4% revenue decline to $45.4 million in Q2 2026, though adjusted EBITDA loss narrowed and cash usage significantly decreased. The company is experiencing increased adoption of new bunion systems and expects improved performance in the latter half …

Treace Medical Concepts Releases Q2 2026 Financial Results

Treace Medical Concepts, Inc. (TMCI) reported a narrower Q2 2026 loss per share of -$0.24, beating the -$0.30 estimate by 20.0%. The company's revenue for the quarter was $45.4 million, representing a 4.0% year-over-year decrease. Management projects full-year revenue to be between $204.0 million …

TriSalus Life Sciences earnings missed by $0.01, revenue topped estimates

TriSalus Life Sciences (NASDAQ: TLSI) reported second-quarter EPS that missed analyst estimates by $0.01, coming in at $-0.160. However, the company's revenue for the quarter exceeded expectations, reaching $11.41 million against a consensus estimate of $10.79 million. Despite the EPS miss, TriSalus Life Sciences' …

Tandem Diabetes Care Announces Second Quarter 2026 Financial Results

Tandem Diabetes Care, Inc. reported strong financial results for Q2 2026, with worldwide sales increasing 6% to $254.6 million and gross margin up 460 basis points to 57%. The company also highlighted strategic achievements, including FDA submissions for Tandem Mobi, expanded global technology solutions, …

Tandem Diabetes Care Inc (TNDM) News, Articles, Events & Latest Updates

Tandem Diabetes Care Inc (TNDM) reported Q2 2026 financial results, including a loss and lagging revenue estimates, despite some key metrics showing positive movement. The company announced upcoming conference presentations, product compatibility expansions, and plans to release Q2 results in August 2026. This news …

Tandem Diabetes Care, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TNDM)

Tandem Diabetes Care, Inc. published its Q2 2026 earnings call presentation, reporting an EPS of -$0.31, which beat estimates by $0.01. The company's revenue for the quarter was $254.56M, representing a 5.77% year-over-year increase, though it missed revenue expectations by $510.18K. The slide deck …

Neuronetics Inc expected to post a loss of 12 cents a share - Earnings Preview

Neuronetics Inc is projected to report a loss of 12 cents per share, according to an earnings preview. The article, sourced from Reuters, provides this financial expectation. Readers can access the full article through TradingView.

QUANTERIX Q2 2026 Earnings Preview: Recent $QTRX Insider Trading, Hedge Fund Activity, and More

Rapid Micro Biosystems, Inc. Q2 2026 Earnings Call Summary

Elutia Receives Nasdaq Notice on Listing Compliance Risk

Elutia Inc. (ELUT) received a notice from Nasdaq stating that its Class A common stock has fallen below the minimum $1.00 per share bid price for 30 consecutive business days, putting it at risk of delisting. The company has until February 2, 2027, to …

Elutia Inc. (NASDAQ: ELUT) faces Nasdaq minimum bid price deficiency

Elutia Inc. (NASDAQ: ELUT) has received a notice from Nasdaq stating that its Class A common stock has traded below the $1.00 minimum bid price for 30 consecutive business days, failing to meet the continued listing requirement. The company has 180 calendar days, until …

Smith & Nephew Is Under Pressure from External Factors and Portfolio Gaps

Smith & Nephew (SNN) is facing pressure due to external factors and gaps in its product portfolio, despite its history of innovation in orthopedics, sports medicine, and wound care markets. The company has shown strength in introducing innovations like Oxinium technology for hip replacements …

IRIDEX Corp (IRIX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for IRIDEX Corp (IRIX), indicating a current earnings forecast score of 8.00 and a "Buy" rating based on one analyst. It details future revenue and EPS expectations, with an anticipated next-quarter revenue of $12.98 million and an EPS …

Net current asset value per share of Insulet Corporation – HAM:GOV

This article displays the "Net current asset value per share" for Insulet Corporation (GOV) on the Hamburg Stock Exchange. The current financial data for the specified period is not available, showing "No trades" as the market is closed. The content primarily consists of navigation …

Boston Scientific (NYSE: BSX) director adds 2,100 shares in open-market buy

Boston Scientific director David C. Habiger purchased 2,100 shares of common stock on August 5, 2026, in an open-market transaction. The shares were bought at a weighted average price of $47.589, with individual trade prices ranging from $47.21 to $47.98. Following this transaction, Habiger …

The Doctor Will See You Now…Everywhere

The heart monitor leader iRhythm Holdings is moving to help doctors track their patients’ health outside the clinic. It’s doing it through an acquisition. Continue Reading

Hyperfine, Inc. Reports Second Quarter 2026 Financial Results

Hyperfine, Inc. announced strong financial results for the second quarter of 2026, with revenues increasing by 44.8% to $3.9 million and a 50% increase in commercial Swoop® system sales. The company achieved key milestones including CE Marking and UKCA approval for its next-generation Swoop® …

Establishment Labs (NASDAQ: ESTA) lifts H1 2026 revenue 37.5% but stays in loss

Establishment Labs (NASDAQ: ESTA) reported strong revenue growth for the first half of 2026, with revenue increasing by 37.5% to $127.4 million, primarily driven by U.S. sales. Despite this growth and an improved gross margin of 70.7%, the company remained unprofitable, posting a net …

InspireMD Approves 221,666 Restricted Shares for New Hire

InspireMD (Nasdaq: NSPR) has granted 221,666 restricted shares to a new non-executive employee as an inducement for employment, in accordance with Nasdaq Listing Rule 5635(c)(4). These shares, granted under the company's 2024 Inducement Plan with a grant date of August 3, 2026, will vest …

Axogen, Inc. SEC Filing (Aug 7, 2026)

This article reports on an SEC Form 144 filing by Axogen, Inc. (AXGN) on August 7, 2026. The filing indicates a proposed sale of 14,150 shares with an aggregate market value of $627,552.50, acquired through Restricted Stock Units on June 19, 2026. The filing …

Profound Medical Corp. 2026: Revenue $2.48M, EPS ($0.26) — 10-Q Summary

Profound Medical Corp. reported its 2026 quarterly results, showing a revenue increase of 12.3% to $2.48 million compared to the previous year. The company also significantly reduced its net loss to ($9.54 million) from ($15.7 million) and improved its diluted loss per share by …

Senseonics (SENS) doubles revenue but widens loss amid 2026 expansion

Senseonics Holdings, Inc. (SENS) reported a significant increase in revenue for the first half of 2026, more than doubling to $26.194 million, primarily due to the commercialization of its Eversense E3 and 365 CGM systems and taking over European distribution. Despite this revenue growth, …

Senseonics Holdings, Inc. Common Stock Q2 Earnings Call Highlights

Senseonics Holdings, Inc. reported a strong second quarter, with revenue surging approximately 120% year-over-year to $14.5 million, primarily driven by U.S. growth and increased adoption of its Eversense continuous glucose monitoring system. The company raised its 2026 revenue guidance to $62 million-$66 million and …

STERIS plc 2026: Revenue $1.49B, EPS $2.04— 10-Q Summary

STERIS plc (STE) reported its 2026 quarterly results with revenue of $1.49 billion and diluted EPS of $2.04, marking significant year-over-year growth in both metrics. The revenue increase of 7.3% was driven by higher volume and pricing, especially in Healthcare and Life Sciences, with …

STERIS plc (NYSE: STE) lifts Q1 2027 revenue to $1.49B, EPS hits $2.04

Inspire Medical Systems, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:INSP) 2026-08-07

Inspire Medical Systems, Inc. (NYSE:INSP) has released its Q2 2026 earnings call presentation, detailing financial results that exceeded analyst expectations. The company reported an EPS of $0.14, beating estimates by $0.39, and revenue of $200.58M, surpassing expectations by $5.97M despite a 7.60% year-over-year decrease. …

Standard BioTools Inc (LAB) Stock News Today

Inspire Medical Systems, Inc. SEC Filing (Aug 7, 2026)

This article reports on an SEC Form 144 filing by Inspire Medical Systems, Inc. (INSP) on August 7, 2026. The filing indicates a proposed sale of 963 shares of common stock with an aggregate market value of $57,341.84 by a person related to the …

CytoSorbents (NASDAQ: CTSO) posts Q2 2026 revenue of $9.6M and narrows loss

CytoSorbents reported Q2 2026 revenue of $9.6 million, flat year-over-year, driven by growth from distributors and direct international sales offsetting a decline in Germany. The company narrowed its operating loss to ($2.6 million) and achieved a net income of $1.9 million, or $0.03 per …

CEO Cary Vance to Speak at AVITA Medical Conference Aug. 12

AVITA Medical (NASDAQ: RCEL, ASX: AVH) announced its participation in the Canaccord Genuity 46th Annual Growth Conference in Boston from August 11–13, 2026. President and CEO Cary Vance is scheduled to speak on August 12, 2026, at 8:00 a.m. Eastern Time. A live webcast …

AVITA Medical Announces Participation at Canaccord Genuity Growth Conference

AVITA Medical, Inc. announced its participation in the Canaccord Genuity 46th Annual Growth Conference in Boston from August 11–13, 2026. The company's President and CEO, Cary Vance, is scheduled to speak on August 12, 2026, at 8:00 a.m. Eastern Time. A live webcast and …

What Do Boston Scientific (BSX) Recalls Mean For Device Safety And Clinical Use?

Boston Scientific (NYSE: BSX) has initiated multiple Class II product recalls for cardiac ablation generators and vascular access sheaths due to issues like labeling discrepancies and air embolism risks. These recalls affect devices crucial to electrophysiology and interventional oncology, raising questions about Boston Scientific's …

How Abbott Laboratories (ABT) Affects Rotational Strategy Timing

This article analyzes Abbott Laboratories (ABT) through the lens of rotational strategy timing, utilizing AI models to generate trading strategies. It highlights mixed sentiment, no clear price positioning signal, and compelling upside potential due to the absence of resistance levels above the current price. …

Delcath Systems Inc (DCTH) Stock News Today